| Net income | 246.2M |
| Depreciation and amortization expense | 166.7M |
| Deferred income tax benefit | 500K |
| (Gain) loss on sales of property, plant and equipment | -1.1M |
| Equity in earnings of unconsolidated entities | |
| Dividends received from unconsolidated entity | |
| Share based compensation expense | 17.8M |
| Tax deficit (excess benefit) from share based compensation | |
| Net loss from life insurance policies | |
| Accounts receivable | -112M |
| Inventories | -95.5M |
| Prepaid expenses and other assets | 35.2M |
| Accounts payable and other liabilities | 72.2M |
| Net cash used in operating activities | |
| Purchases of property, plant and equipment | -110.6M |
| Proceeds from sales of property, plant and equipment | |
| Net proceeds from redemption of life insurance policies | |
| Net cash used in investing activities | |
| Net short-term debt borrowings | -11.9M |
| Proceeds from long-term debt borrowings | 1.71B |
| Principal payments on long-term debt | -1.53B |
| Payments to noncontrolling interest holders | |
| Dividends paid | |
| (Tax deficit) excess benefit from share based compensation | |
| Exercise of stock options | 31.3M |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Increase in cash and cash equivalents | 39M |
| Cash and cash equivalents at beginning of year | 104.3M |
| Cash and cash equivalents at end of period | 143.3M |
| Interest paid during the period | |
| Income taxes paid during the period | |